E2F1 and prostate carcinoma: Further peak visualization of ChIP-sequencing data in both prostate cancer cell LNCaP and abl showed significant binding enrichment of E2F1 within the promoters of CDRs (Fig. 5B), which was further validated with ChIP-qPCR experiments in prostate cancer cells (Fig. 5C).